Literature DB >> 21575084

Plasma carotenoids are related to intima--media thickness of the carotid artery wall in men from eastern Finland.

J Karppi1, S Kurl, J A Laukkanen, T H Rissanen, J Kauhanen.   

Abstract

BACKGROUND: Several previous epidemiological studies have suggested that high plasma concentrations of carotenoids may slow the development of early atherosclerosis, but results have been inconclusive.
METHODS: We examined the effect of carotenoids on early atherosclerosis in a population-based study. The association between plasma carotenoid concentrations and intima-media thickness of the common carotid artery (CCA-IMT) was investigated in 1212 elderly men (aged 61-80 years) in Eastern Finland. They were examined by B-mode ultrasound to detect early signs of carotid atherosclerosis, and plasma concentrations of carotenoids were measured by high-performance liquid chromatography.
RESULTS: Men in the lowest quartile of CCA-IMT had significantly higher concentrations of plasma β-cryptoxanthin, lycopene and α-carotene than men in the highest quartile (P for the differences: 0.043, 0.045 and 0.046, respectively), after adjustment for age, examination year, body mass index, smoking, alcohol intake, years of education, symptomatic coronary heart disease (CHD) or CHD history, diabetes, low-density lipoprotein cholesterol, medications and season. The concentrations of plasma β-cryptoxanthin, lycopene and α-carotene decreased linearly with increasing CCA-IMT.
CONCLUSIONS: The results of this study suggest that high plasma concentrations of β-cryptoxanthin, lycopene and α-carotene may be associated with decreased carotid atherosclerosis in elderly men from eastern Finland.
© 2011 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575084     DOI: 10.1111/j.1365-2796.2011.02401.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Effects of lycopene on the initial state of atherosclerosis in New Zealand White (NZW) rabbits.

Authors:  Mario Lorenz; Mandy Fechner; Janine Kalkowski; Kati Fröhlich; Anne Trautmann; Volker Böhm; Gerhard Liebisch; Stefan Lehneis; Gerd Schmitz; Antje Ludwig; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

Review 2.  Lycopene and Vascular Health.

Authors:  Ioana Mozos; Dana Stoian; Alexandru Caraba; Clemens Malainer; Jarosław O Horbańczuk; Atanas G Atanasov
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

Review 3.  Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?

Authors:  Paola Toledo-Ibelles; Jaime Mas-Oliva
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

Review 4.  Influence of Bioactive Nutrients on the Atherosclerotic Process: A Review.

Authors:  Rosa Casas; Ramon Estruch; Emilio Sacanella
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

Review 5.  Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease.

Authors:  Denise Burtenshaw; Michael Kitching; Eileen M Redmond; Ian L Megson; Paul A Cahill
Journal:  Front Cardiovasc Med       Date:  2019-08-02

6.  Serum carotenoids reduce progression of early atherosclerosis in the carotid artery wall among Eastern Finnish men.

Authors:  Jouni Karppi; Sudhir Kurl; Kimmo Ronkainen; Jussi Kauhanen; Jari A Laukkanen
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

7.  The chemopreventive potential of lycopene against atrazine-induced cardiotoxicity: modulation of ionic homeostasis.

Authors:  Jia Lin; Hui-Xin Li; Jun Xia; Xue-Nan Li; Xiu-Qing Jiang; Shi-Yong Zhu; Jing Ge; Jin-Long Li
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

Review 8.  Nutraceuticals as therapeutic agents for atherosclerosis.

Authors:  Joe W E Moss; Jessica O Williams; Dipak P Ramji
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-02-14       Impact factor: 5.187

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.